Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.03.17.533157v1?rss=1

Authors: Hindi, S., Petrany, M., Greenfeld, E., Focke, L., Cramer, A., Whitt, M., Prasad, V., Chamberlain, J., Podbilewicz, B., Millay, D.

Abstract:
Entry of enveloped viruses into cells is mediated by fusogenic proteins that form a complex between membranes to drive rearrangements needed for fusion. Skeletal muscle development also requires membrane fusion events between progenitor cells to form multinucleated myofibers. Myomaker and Myomerger are muscle-specific cell fusogens, but do not structurally or functionally resemble classical viral fusogens. We asked if the muscle fusogens could functionally substitute for viral fusogens, despite their structural distinctiveness, and fuse viruses to cells. We report that engineering of Myomaker and Myomerger on the membrane of enveloped viruses leads to specific transduction of skeletal muscle. We also demonstrate that locally and systemically injected virions pseudotyped with the muscle fusogens can deliver micro-Dystrophin (uDys) to skeletal muscle of a mouse model of Duchenne muscular dystrophy. Through harnessing the intrinsic properties of myogenic membranes, we establish a platform for delivery of therapeutic material to skeletal muscle.

Copy rights belong to original authors. Visit the link for more info

Podcast created by Paper Player, LLC